Tata Communications Allots Non-Convertible Debentures Worth Rs 1,750 Cr

Tata Communications Allots Non-Convertible Debentures Worth Rs 1,750 Cr

The NCDs have a fixed rate coupon of 7.75 percent and have been issued on the basis of multiple yield allotment method.

FPJ Web DeskUpdated: Tuesday, August 29, 2023, 06:53 PM IST
article-image
Tata Communications Allots Non-Convertible Debentures Worth Rs 1,750 Cr | Image: Tata Communications (Representative)

Tata Communications on Tuesday through an exchange file informed that the Financial Resource Raising Committee has today approved the allotment of 1,75,000 Rated, Unsecured, Listed, Redeemable Non-Convertible Debentures (NCDs) having face value of Rs 1,00,000 each, for cash, aggregating to Rs 1,750 crore, for a tenor of 3 years, to identified investors on private placement basis, on the terms and conditions as mentioned in the transaction documents for the issuance.

The NCDs have a fixed rate coupon of 7.75 percent and have been issued on the basis of multiple yield allotment method.

The NCDs will be listed on the Wholesale Debt Market Segment of the National Stock Exchange of India Limited.

Tata Communications shares

The shares of Tata Communications on Tuesday at 3:30pm IST were at Rs 1,792.50, down by 0.29 percent.

(To receive our E-paper on WhatsApp daily, please click here.  To receive it on Telegram, please click here. We permit sharing of the paper's PDF on WhatsApp and other social media platforms.)

RECENT STORIES

India's April-August Fiscal Deficit Rises To ₹6.43 Lakh Crore

India's April-August Fiscal Deficit Rises To ₹6.43 Lakh Crore

Rupee Rises 14 Paise To 83.05 Against US Dollar

Rupee Rises 14 Paise To 83.05 Against US Dollar

Crypto Icons: India's Best And Brightest Crypto Leaders In The Industry

Crypto Icons: India's Best And Brightest Crypto Leaders In The Industry

Closing Bell: Markets End Day In Positive; Sensex At 65,828.41, Nifty Above 19,600

Closing Bell: Markets End Day In Positive; Sensex At 65,828.41, Nifty Above 19,600

Lupin Receives EIR From U.S. FDA For Its Nagpur Unit-1 Manufacturing Facility

Lupin Receives EIR From U.S. FDA For Its Nagpur Unit-1 Manufacturing Facility